ENTA earnings: a negative outcome, -7.9%

On May 9, 2022, Enanta Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.9% in the window around the event. It had already run -23.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.